ALLO Allogene Therapeutics, Inc. - Common Stock
ALLO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
ALLO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
ALLO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 6 33.3%
- 매수 10 55.6%
- 보유 2 11.1%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
9 명의 애널리스트 · 2026-08-15실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.13 | $-0.17 | 0.04% |
| 2026년 3월 31일 | $-0.18 | $-0.19 | 0.01% |
| 2025년 12월 31일 | $-0.17 | $-0.22 | 0.05% |
| 2025년 9월 30일 | $-0.19 | $-0.23 | 0.04% |
| 2025년 6월 30일 | $-0.23 | $-0.28 | 0.05% |
| 2025년 3월 31일 | $-0.28 | $-0.30 | 0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| R&D Expense | $150M | $192M | $243M | $256M | $220M | $193M | $145M | |
| SG&A Expense | $57M | $65M | $72M | $79M | $74M | $65M | $57M | |
| Operating Expenses | $209M | $273M | $328M | $336M | $294M | $258M | $202M | |
| Operating Income | $-209M | $-273M | $-328M | $-336M | $-180M | $-258M | $-202M | |
| Interest Expense | · | · | · | · | · | $0 | $0 | |
| Other Non-op | $215.0K | $-4M | $-18M | $-9M | $-4M | $-67M | $17M | |
| Pretax Income | $-191M | $-257M | $-327M | · | $-257M | $-250M | $-185M | |
| Income Tax | $0 | $443.0K | $0 | $0 | $0 | $0 | $-331.0K | |
| Net Income | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| EPS (Basic) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| EPS (Diluted) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| Shares (Basic) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| Shares (Diluted) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| EBITDA | $-197M | $-260M | $-314M | · | $-245M | $-251M | $-197M |
대차대조표 21
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $75M | $83M | $62M | $173M | $183M | $175M | |
| Short-term Investments | · | · | · | · | $284M | $645M | $355M | |
| Prepaid Expense | $8M | $11M | $10M | $12M | $14M | $17M | $14M | |
| Current Assets | $258M | $303M | $459M | $529M | $471M | $845M | $545M | |
| PP&E (Net) | $73M | $86M | $99M | $113M | $123M | $119M | $56M | |
| PP&E (Gross) | $145M | $149M | $151M | $150M | $146M | $132M | $62M | |
| Accum. Depreciation | $73M | $63M | $51M | $37M | $23M | $13M | $5M | |
| Intangibles | · | · | · | · | · | $0 | $151.0K | |
| Other Non-current Assets | $4M | $2M | $7M | $10M | $6M | $5M | $5M | |
| Total Assets | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Accounts Payable | $4M | $5M | $6M | $14M | $10M | $10M | $9M | |
| Current Liabilities | $33M | $36M | $37M | $54M | $48M | $94M | $33M | |
| Capital Leases | $75M | $83M | $88M | $95M | $70M | $51M | $51M | |
| Other Non-current Liabilities | $16M | $8M | $5M | $6M | $8M | $3M | $4M | |
| Total Liabilities | $123M | $127M | $131M | $155M | $126M | $148M | $89M | |
| Common Stock | $229.0K | $212.0K | $169.0K | $144.0K | $142.0K | $140.0K | $124.0K | |
| Retained Earnings | $-2.01B | $-1.82B | $-1.56B | $-1.23B | $-895M | $-713M | $-396M | |
| AOCI | $269.0K | $-89.0K | $-955.0K | $-10M | $-3M | $268.0K | $1M | |
| Stockholders' Equity | $293M | $422M | $512M | $667M | $925M | $1.01B | $629M | |
| Liabilities + Equity | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Shares Outstanding | 229,413,523 | 212,210,597 | 168,642,238 | 144,438,304 | 142,623,065 | 140,474,305 | 124,267,358 |
현금 흐름 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $14M | $14M | $14M | $10M | $7M | $5M | |
| Stock-based Comp | $38M | $52M | $66M | $84M | $81M | $65M | $46M | |
| Deferred Tax | $0 | $443.0K | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | $0 | $0 | $151.0K | $603.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-8M | $-9M | $9M | · | $-19M | $62M | $-3M | |
| Operating Cash Flow | $-149M | $-200M | $-238M | $-221M | $-185M | $-115M | $-137M | |
| CapEx | $386.0K | $694.0K | $2M | $5M | $21M | $66M | $51M | |
| Investing Cash Flow | $96M | $76M | $163M | $106M | $164M | $-505M | $164M | |
| Stock Issued | · | · | $91M | $0 | $0 | $596M | $0 | |
| Net Stock Activity | · | · | $91M | · | $0 | $622M | $54M | |
| Financing Cash Flow | $30M | $117M | $96M | $3M | $12M | $634M | $59M | |
| Net Change in Cash | $-24M | $-8M | $21M | $-111M | $-9M | $13M | $86M | |
| Free Cash Flow | $-150M | $-201M | $-239M | · | $-206M | $-181M | $-188M | |
| Levered FCF | · | · | · | · | · | $-181M | $-188M |
수익성 7
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1241813.6% | -344986.3% | · | -664.6% | · | · | |
| Net Margin | · | -1170863.6% | -344489.5% | · | -667.7% | · | · | |
| Pretax Margin | · | -1168850.0% | · | · | -667.7% | · | · | |
| EBITDA Margin | · | -1179818.2% | -330039.0% | · | -637.3% | · | · | |
| ROA | -39.6% | -43.2% | -48.3% | · | -22.7% | -25.7% | -24.8% | |
| ROE | -59.9% | -58.1% | -59.9% | · | -27.3% | -22.8% | -29.6% | |
| ROIC | -71.5% | -64.8% | · | · | -27.9% | -23.9% | -32.1% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.5 | 12.4 | · | 9.8 | 9.0 | 16.5 | |
| Quick Ratio | 1.6 | 2.1 | 2.2 | · | 9.5 | 8.8 | 16.0 |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · |
성장률 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -76.8% | -39.1% | -99.9% | · | · | · | |
| Revenue CAGR 3Y | · | -94.2% | · | · | · | · | · |
가치 평가 (TTM) 10
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| Net Income TTM | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| Market Cap | $314M | $452M | $541M | · | $2.13B | $3.55B | $3.23B | |
| P/E | -1.6 | -1.6 | -1.5 | -2.6 | -11.1 | -9.6 | -14.2 | |
| P/S | · | 20545.8 | 5698.3 | · | 18.7 | · | · | |
| P/B | 1.1 | 1.1 | 1.1 | · | 2.3 | 3.3 | 5.1 | |
| P / Tangible Book | 1.1 | 1.1 | 1.1 | 1.4 | 2.3 | 3.5 | · | |
| P / Cash Flow | -2.1 | -2.3 | -2.3 | · | -11.5 | -30.8 | -23.5 | |
| P / FCF | -2.1 | -2.2 | -2.3 | · | -10.3 | -19.6 | -17.2 | |
| Earnings Yield | -63.5% | -62.0% | -65.1% | -37.8% | -9.0% | -10.4% | -7.0% |
손익계산서 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22.0K | $21.0K | $22.0K | $22.0K | $30.0K | $-40.0K | $27.0K | |
| R&D Expense | $31M | $32M | $29M | $31M | $40M | $50M | $45M | $45M | $50M | $52M | $55M | $46M | $62M | $80M | $75M | $64M | |
| SG&A Expense | $21M | $14M | $14M | $14M | $14M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $19M | $19M | $21M | $19M | |
| Operating Expenses | $52M | $46M | $42M | $45M | $57M | $65M | $60M | $72M | $71M | $70M | $85M | $63M | $81M | $99M | $96M | $83M | |
| Operating Income | $-47M | $-46M | $-42M | $-45M | $-57M | $-65M | $-60M | $-72M | $-71M | $-70M | $-85M | $-63M | $-81M | $-99M | $-96M | $-83M | |
| Other Non-op | $-61.0K | $212.0K | $247.0K | $-81.0K | $-43.0K | $92.0K | $-2M | $-1M | $85.0K | $-929.0K | $-12M | $-5M | $-2M | $2M | $-10M | $-3M | |
| Net Income | $-43M | $-43M | $-39M | $-41M | $-51M | $-60M | $-60M | $-66M | $-66M | $-65M | $-86M | $-62M | $-79M | $-100M | $-103M | $-84M | |
| EPS (Basic) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| EPS (Diluted) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| Shares (Basic) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| Shares (Diluted) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| EBITDA | $-47M | $-43M | · | $-45M | $-57M | $-62M | · | $-72M | $-71M | $-70M | · | $-63M | $-81M | $-99M | · | $-82M |
대차대조표 19
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $30M | $52M | $38M | $52M | $42M | $75M | $51M | $171M | $51M | $83M | $69M | $155M | $110M | $62M | $74M | |
| Prepaid Expense | $7M | $6M | $8M | $9M | $10M | $12M | $11M | $13M | $12M | $11M | $10M | $8M | $10M | $10M | $12M | $17M | |
| Current Assets | $340M | $273M | $258M | $261M | $283M | $292M | $303M | $304M | $457M | $395M | $459M | $473M | $502M | $481M | $529M | $569M | |
| PP&E (Net) | $67M | $70M | $73M | $76M | $79M | $83M | $86M | $89M | $92M | $96M | $99M | $103M | $106M | $110M | $113M | $114M | |
| PP&E (Gross) | $145M | $145M | $145M | $145M | $146M | $149M | $149M | $149M | $148M | $151M | $151M | $150M | $150M | $150M | $150M | $149M | |
| Accum. Depreciation | $78M | $75M | $73M | $70M | $67M | $66M | $63M | $60M | $56M | $55M | $51M | $48M | $44M | $40M | $37M | $35M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $5M | $6M | $5M | $7M | $10M | $9M | $9M | $10M | $9M | |
| Total Assets | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Accounts Payable | $6M | $5M | $4M | $4M | $5M | $5M | $5M | $6M | $13M | $6M | $6M | $6M | $10M | $15M | $14M | $11M | |
| Current Liabilities | $32M | $28M | $33M | $32M | $32M | $30M | $36M | $33M | $37M | $31M | $37M | $38M | $55M | $60M | $54M | $49M | |
| Capital Leases | $70M | $73M | $75M | $77M | $79M | $81M | $83M | $85M | $87M | $89M | $88M | $90M | $92M | $94M | $95M | $97M | |
| Other Non-current Liabilities | $12M | $16M | $16M | $15M | $15M | $11M | $8M | $8M | $8M | $5M | $5M | $1M | $2M | $2M | $6M | $2M | |
| Total Liabilities | $114M | $117M | $123M | $124M | $126M | $123M | $127M | $125M | $132M | $125M | $131M | $129M | $148M | $155M | $155M | $148M | |
| Common Stock | $345.0K | $245.0K | $229.0K | $223.0K | $220.0K | $219.0K | $212.0K | $210.0K | $209.0K | $170.0K | $169.0K | $168.0K | $167.0K | $146.0K | $144.0K | $144.0K | |
| Retained Earnings | $-2.10B | $-2.05B | $-2.01B | $-1.97B | $-1.93B | $-1.88B | $-1.82B | $-1.76B | $-1.69B | $-1.63B | $-1.56B | $-1.47B | $-1.41B | $-1.33B | $-1.23B | $-1.14B | |
| AOCI | $-518.0K | $-183.0K | $269.0K | $235.0K | $-45.0K | $43.0K | $-89.0K | $157.0K | $-780.0K | $-927.0K | $-955.0K | $-2M | $-4M | $-6M | $-10M | $-13M | |
| Stockholders' Equity | $436M | $279M | $293M | $315M | $345M | $385M | $422M | $464M | $515M | $461M | $512M | $583M | $623M | $592M | $667M | $740M | |
| Liabilities + Equity | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Shares Outstanding | 345,345,427 | 244,816,413 | 229,413,523 | 223,163,672 | 220,133,876 | 218,598,262 | 212,210,597 | 209,500,137 | 209,049,485 | 170,452,967 | 168,642,238 | 168,175,221 | 167,133,664 | 145,740,333 | 144,438,304 | 144,031,588 |
현금 흐름 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | · | · | · | · | |
| Stock-based Comp | $12M | $8M | $8M | $9M | $9M | $12M | $13M | $13M | $14M | $12M | $15M | $15M | $17M | $19M | $17M | $21M | |
| Restructuring | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $19M | · | · | · | $-8M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-13M | $-28M | $-30M | $-39M | $-53M | $-37M | $-44M | $-64M | $-56M | $-54M | $-56M | $-62M | $-67M | $-62M | $-48M | |
| CapEx | $150.0K | $9.0K | $0 | $243.0K | $44.0K | $99.0K | $257.0K | $429.0K | $0 | $8.0K | $181.0K | $12.0K | $288.0K | $1M | $2M | $223.0K | |
| Investing Cash Flow | $-148M | $-30M | $34M | $12M | $44M | $6M | $55M | $-76M | $75M | $22M | $67M | $-34M | $17M | $113M | $50M | $25M | |
| Stock Issued | · | · | · | · | · | $10M | · | · | · | $0 | · | $3M | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $10M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $188M | $21M | $8M | $3M | $5M | $14M | $6M | $679.0K | $109M | $2M | $155.0K | $4M | $90M | $2M | $46.0K | $1M | |
| Net Change in Cash | $8M | $-21M | $14M | $-15M | $10M | $-33M | $24M | $-119M | $120M | $-32M | $14M | $-86M | $45M | $48M | $-12M | $-22M | |
| Free Cash Flow | · | $-13M | · | · | · | $-53M | · | · | · | $-56M | · | · | · | $-68M | · | · |
수익성 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| Net Margin | -919.8% | · | · | · | · | · | · | · | · | -295454.6% | · | -142593.0% | -177247.7% | -189815.4% | · | -169689.8% | |
| EBITDA Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| ROA | -8.4% | -9.4% | · | -8.1% | -9.1% | -10.9% | · | -10.2% | -9.4% | -9.8% | · | -7.7% | -9.1% | -11.5% | · | -8.5% | |
| ROE | -10.9% | -12.8% | · | -10.6% | -11.8% | -14.1% | · | -12.7% | -11.7% | -12.3% | · | -9.3% | -10.9% | -13.6% | · | -9.7% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | 9.6 | · | 8.2 | 8.9 | 9.7 | · | 9.3 | 12.3 | 12.8 | · | 12.6 | 9.2 | 8.1 | · | 11.6 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.2 | 1.7 | 1.4 | · | 1.6 | 4.6 | 1.7 | · | 1.8 | 2.8 | 1.8 | · | 1.5 |
효율성 1
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
가치 평가 (TTM) 10
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | · | $0 | $0 | $22.0K | · | $44.0K | $66.0K | $96.0K | · | $101.0K | $143.0K | $160.0K | · | $179.0K | |
| Net Income TTM | $-178M | $-195M | · | $-218M | $-243M | $-257M | · | $-260M | $-273M | $-306M | · | $-326M | $-344M | $-343M | · | $-321M | |
| Market Cap | $718M | $597M | · | $277M | $249M | $319M | · | $587M | $487M | $762M | · | $533M | $831M | $720M | · | $1.56B | |
| P/E | -2.8 | -2.8 | · | -1.2 | -1.0 | -1.1 | · | -2.0 | -1.4 | -2.3 | · | -1.4 | -2.1 | -2.1 | · | -4.7 | |
| P/S | · | · | · | · | · | 14507.0 | · | 13331.8 | 7380.1 | 7936.7 | · | 5278.4 | 5808.8 | 4499.7 | · | 8690.2 | |
| P/B | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Cash Flow | · | -46.3 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.8 | · | · | |
| P / FCF | · | -46.2 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.6 | · | · | |
| Earnings Yield | -35.1% | -36.1% | · | -82.3% | -104.4% | -91.1% | · | -50.7% | -70.4% | -44.3% | · | -69.1% | -47.9% | -48.6% | · | -21.1% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 매출 | $0 | $22.0K | $95.0K | — | — |
| 영업이익률 % | — | -1241813.6% | -344986.3% | — | — |
| 순이익 | $-191M | $-258M | $-327M | — | — |
| 희석 EPS | $-0.87 | $-1.32 | $-2.09 | — | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 유동비율 | 7.9 | 8.5 | 12.4 | — | — |
| 당좌 비율 | 1.6 | 2.1 | 2.2 | — | — |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-150M | $-201M | $-239M | — | — |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 231개의 제출자 · $530.0M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 37 (-10 이전 분기 대비) | 24 (+13 이전 분기 대비) | 90 (+13 이전 분기 대비) | 55 (+12 이전 분기 대비) | +123.4M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| Pfizer Inc | $46,928,245 | 22,032,040 | 8.85% | 주식 |
| Frazier Life Sciences Management, L.P. | $46,689,069 | 22,446,668 | 8.81% | 주식 |
| STATE STREET CORP | $39,573,718 | 19,025,826 | 7.47% | 주식 |
| TPG GP A, LLC | $38,929,916 | 18,716,306 | 7.34% | 주식 |
| Sio Capital Management, LLC | $27,712,736 | 13,323,431 | 5.23% | 주식 |
| PRIMECAP MANAGEMENT CO/CA/ | $27,296,756 | 13,123,440 | 5.15% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $25,306,603 | 12,166,636 | 4.77% | 주식 |
| FMR LLC | $24,957,776 | 11,998,931 | 4.71% | 주식 |
| CITADEL ADVISORS LLC | $19,676,871 | 9,460,034 | 3.71% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $16,191,444 | 7,784,348 | 3.05% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $12,494,150 | 6,005,150 | 2.36% | 주식 |
| GOLDMAN SACHS GROUP INC | $12,467,422 | 5,993,953 | 2.35% | 주식 |
| VANGUARD GROUP INC | $11,178,392 | 8,159,410 | 2.11% | 주식 |
| GordonMD Global Investments LP | $11,019,840 | 5,298,000 | 2.08% | 주식 |
| Patient Square Capital LP | $10,504,000 | 5,050,000 | 1.98% | 주식 |
| Aberdeen Group plc | $10,403,644 | 5,001,752 | 1.96% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $10,075,289 | 4,843,889 | 1.90% | 주식 |
| Woodline Partners LP | $9,361,298 | 4,500,624 | 1.77% | 주식 |
| Candriam S.C.A. | $9,010,818 | 4,336,296 | 1.70% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8,761,122 | 4,212,078 | 1.65% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $7,975,369 | 3,834,312 | 1.50% | 주식 |
| Walleye Capital LLC | $6,797,465 | 3,268,012 | 1.28% | 주식 |
| RTW INVESTMENTS, LP | $6,760,000 | 3,250,000 | 1.28% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $6,397,849 | 3,075,889 | 1.21% | 주식 |
| Ghisallo Capital Management LLC | $6,240,000 | 3,000,000 | 1.18% | 주식 |
| Wildcat Capital Management, LLC | $6,075,237 | 2,920,787 | 1.15% | 주식 |
| BANK OF AMERICA CORP /DE/ | $6,043,750 | 2,905,649 | 1.14% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4,730,675 | 2,274,363 | 0.89% | 주식 |
| DAFNA Capital Management LLC | $4,160,000 | 2,000,000 | 0.78% | 주식 |
| TWO SIGMA ADVISERS, LP | $3,959,574 | 2,890,200 | 0.75% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $3,823,756 | 1,838,344 | 0.72% | 주식 |
| Boxer Capital Management, LLC | $3,120,000 | 1,500,000 | 0.59% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3,026,614 | 1,455,103 | 0.57% | 주식 |
| Raiffeisen Bank International AG | $2,442,000 | 1,100,000 | 0.46% | 주식 |
| Vida Ventures Advisors, LLC | $2,229,722 | 1,798,163 | 0.42% | 주식 |
| BlackRock, Inc. | $2,142,876 | 1,030,229 | 0.40% | 주식 |
| Man Group plc | $1,459,954 | 701,901 | 0.28% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $1,412,262 | 678,972 | 0.27% | 주식 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1,138,153 | 547,189 | 0.21% | 주식 |
| CITIGROUP INC | $1,038,914 | 499,478 | 0.20% | 주식 |
| Voleon Capital Management LP | $1,010,092 | 485,621 | 0.19% | 주식 |
| AMERIPRISE FINANCIAL INC | $977,182 | 469,799 | 0.18% | 주식 |
| TD Asset Management Inc | $961,126 | 462,080 | 0.18% | 주식 |
| MACKENZIE FINANCIAL CORP | $893,489 | 429,562 | 0.17% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $886,650 | 426,274 | 0.17% | 주식 |
| Erste Asset Management GmbH | $846,708 | 381,400 | 0.16% | 주식 |
| ALPS ADVISORS INC | $728,630 | 350,303 | 0.14% | 주식 |
| Rafferty Asset Management, LLC | $702,073 | 337,535 | 0.13% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $666,114 | 320,247 | 0.13% | 주식 |
| RHUMBLINE ADVISERS | $644,248 | 309,741 | 0.12% | 주식 |
| Moloney Securities Asset Management, LLC | $637,360 | 514,000 | 0.12% | 주식 |
| Harold Davidson & Associates Inc. | $585,566 | 281,522 | 0.11% | 주식 |
| IEQ CAPITAL, LLC | $582,257 | 279,931 | 0.11% | 주식 |
| Bank of New York Mellon Corp | $558,216 | 268,373 | 0.11% | 주식 |
| HSBC HOLDINGS PLC | $557,157 | 259,747 | 0.11% | 주식 |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $554,147 | 266,417 | 0.10% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $551,142 | 225,878 | 0.10% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $520,000 | 250,000 | 0.10% | 주식 |
| Squarepoint Ops LLC | $502,370 | 241,524 | 0.09% | 주식 |
| UBS Group AG | $494,220 | 237,606 | 0.09% | 주식 |
| BIT Capital GmbH | $478,400 | 230,000 | 0.09% | 주식 |
| WELLS FARGO & COMPANY/MN | $462,342 | 222,280 | 0.09% | 주식 |
| LPL Financial LLC | $458,994 | 220,670 | 0.09% | 주식 |
| Vanguard Global Advisers, LLC | $447,585 | 215,185 | 0.08% | 주식 |
| CAXTON ASSOCIATES LP | $439,589 | 206,380 | 0.08% | 주식 |
| Quadrature Capital Ltd | $437,825 | 210,493 | 0.08% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $431,400 | 207,404 | 0.08% | 주식 |
| Headlands Technologies LLC | $427,342 | 205,453 | 0.08% | 주식 |
| BARCLAYS PLC | $383,836 | 184,536 | 0.07% | 주식 |
| OpenArc Corporate Advisory, LLC | $362,457 | 174,258 | 0.07% | 주식 |
| CWM, LLC | $359,063 | 147,157 | 0.07% | 주식 |
| Virtus Investment Advisers, LLC | $358,195 | 172,209 | 0.07% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $354,432 | 170,400 | 0.07% | 콜 옵션 |
| PROFUND ADVISORS LLC | $352,972 | 169,698 | 0.07% | 주식 |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | $336,122 | 161,597 | 0.06% | 주식 |
| WINTON GROUP Ltd | $328,973 | 158,160 | 0.06% | 주식 |
| MetLife Investment Management, LLC | $324,844 | 156,175 | 0.06% | 주식 |
| Smartleaf Asset Management LLC | $306,080 | 137,874 | 0.06% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $305,000 | 146,779 | 0.06% | 주식 |
| JPMORGAN CHASE & CO | $291,295 | 131,214 | 0.05% | 주식 |
| MARSHALL WACE, LLP | $290,479 | 139,653 | 0.05% | 주식 |
| CHOREO, LLC | $260,129 | 125,062 | 0.05% | 주식 |
| ALGERT GLOBAL LLC | $254,634 | 122,420 | 0.05% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $254,234 | 122,228 | 0.05% | 주식 |
| Quantbot Technologies LP | $243,221 | 116,933 | 0.05% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $240,240 | 115,500 | 0.05% | 주식 |
| Graham Capital Management, L.P. | $237,992 | 114,419 | 0.04% | 주식 |
| Invesco Ltd. | $215,130 | 103,428 | 0.04% | 주식 |
| Engineers Gate Manager LP | $204,903 | 98,511 | 0.04% | 주식 |
| BANK OF NOVA SCOTIA | $202,592 | 97,400 | 0.04% | 주식 |
| Xcelsior Advisor Partners LLC | $199,661 | 95,991 | 0.04% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $194,773 | 93,641 | 0.04% | 주식 |
| AXQ CAPITAL, LP | $173,091 | 83,217 | 0.03% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $171,392 | 82,400 | 0.03% | 풋 옵션 |
| Mariner, LLC | $167,681 | 80,616 | 0.03% | 주식 |
| CAPTRUST FINANCIAL ADVISORS | $164,730 | 79,197 | 0.03% | 주식 |
| MORGAN STANLEY | $164,104 | 78,896 | 0.03% | 주식 |
| Police & Firemen's Retirement System of New Jersey | $162,822 | 78,280 | 0.03% | 주식 |
| D. E. Shaw & Co., Inc. | $157,196 | 75,575 | 0.03% | 주식 |
| CITADEL ADVISORS LLC | $149,344 | 71,800 | 0.03% | 콜 옵션 |
회사 내부자 16 명의 내부자 · 6 임원 · 8 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Zachary Roberts | President and CEO | 2026년 7월 1일 A | — | 0 | 0 | $0 |
| David D Chang | President and CEO | 2022년 3월 23일 A | 2,289,652 | 0 | 0 | $0 |
| Eric Thomas Schmidt | Chief Financial Officer | 2022년 3월 23일 A | 337,904 | 0 | 0 | $0 |
| Rafael Amado | EVP of R&D and CMO | 2022년 6월 21일 S | 544,257 | 0 | 0 | $0 |
| Veer Bhavnagri | General Counsel | 2022년 3월 23일 A | 589,279 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 2022년 3월 23일 A | 120,430 | 0 | 0 | $0 |
| Stephen Mayo | 이사 | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| Elizabeth A. Barrett | 이사 | 2026년 6월 18일 A | — | 0 | 0 | $0 |
| Deborah M. Messemer | 이사 | 2026년 6월 18일 A | 6,535 | 0 | 0 | $0 |
| Owen N. Witte | 이사 | 2026년 6월 18일 A | 233,271 | 0 | 0 | $0 |
| Franz B Humer | 이사 | 2026년 6월 18일 A | 191,892 | 0 | 0 | $0 |
| Joshua A Kazam | 이사 | 2026년 6월 18일 A | 398,463 | 0 | 0 | $0 |
| Vicki L Sato | 이사 | 2026년 6월 18일 A | 41,451 | 0 | 0 | $0 |
| Pfizer Inc. | 10% 소유주 | 2018년 10월 15일 C | 22,032,040 | 0 | 0 | $0 |
| Earl Martin Douglas | — | 2026년 2월 2일 A | 564,948 | 0 | 1 | $-40,304 |
| Arie Belldegrun | — | 2026년 2월 2일 A | 4,710,120 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 5 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Pfizer Inc. | 2026년 2월 13일 | 9.00% | 수정본 | — | SEC |
| Pfizer Inc. (“Pfizer”) ×3 제출 서류 | 2023년 10월 25일 | — | 최초 제출 | — | SEC |
| TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried | 2022년 1월 18일 | — | 최초 제출 | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 제출 서류 | 2020년 8월 10일 | — | 최초 제출 | — | SEC |
| Pfizer Inc. (“ Pfizer ”) | 2018년 10월 22일 | — | 최초 제출 | 수동적 투자 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 30 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1.04% | 182,788 NS | 2026년 4월 30일 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.12% | 303,899 NS | 2026년 4월 30일 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.05% | 496,849 SH | 2026년 8월 8일 | 일간 |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.05% | 18,782 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 588,201 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.04% | 231,043 SH | 2026년 8월 8일 | 일간 |
| IBB · iShares Trust | 0.04% | 1,864,100 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.03% | 2,455,219 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.02% | 8,308 NS | 2026년 5월 31일 | N-PORT |
| SMLF · iShares Trust | 0.02% | 479,966 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.02% | 1,528,157 SH | 2026년 8월 8일 | 일간 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.02% | 27,987 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.02% | 6,776,183 SH | 2026년 8월 8일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.02% | 204,346 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.01% | 876,401 NS | 2026년 4월 30일 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0.01% | 1,207,257 NS | 2026년 5월 31일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 3,222,860 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.01% | 776,881 SH | 2026년 8월 8일 | 일간 |
| ITWO · ProShares Trust | 0.01% | 7,333 NS | 2026년 5월 31일 | N-PORT |
| UWM · ProShares Trust | 0.01% | 5,734 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.00% | 5,798 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 146 NS | 2026년 5월 31일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4,797 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 241,276 NS | 2026년 4월 30일 | N-PORT |
| ITOT · iShares Trust | 0.00% | 356,653 SH | 2026년 8월 8일 | 일간 |
| DFUS · Dimensional ETF Trust | 0.00% | 63,774 NS | 2026년 4월 30일 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0.00% | 149,554 NS | 2026년 5월 31일 | N-PORT |
| IWV · iShares Trust | 0.00% | 25,280 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 8,666,591 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 22,307 SH | 2026년 8월 8일 | 일간 |